TrialSite News Podcast Series is a segment where we talk with patients, doctors, CROs, nurses, clinical researchers and investigators, and clinical site representatives, to give you a full view of healthcare. We want our audience to know the good and the bad happening with clinical trials and research, and to see what is working and what is not.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Media's Viral Lie about Ivermectin Overdoses & Horse Medicine: Dr. Kory Responds | Interview
26:07
In the last few weeks, the mainstream media ran with stories about Ivermectin, most noticeably referring to it as "horse medicine" or "horse dewormer" while, for some reason, leaving out the fact that Ivermectin is a WHO essential medicine for HUMANS. At the same time, the mainstream media and social media ran with a specific story about Oklahoma h…
…
continue reading
An interview with Kelly McKee from Medidata on transforming the patient clinical trial experience.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
CATalyst | Indian Bar Association Serve Legal Notice on WHO's chief scientist Dr. Soumya Swaminathan
54:40
Join the Conversation! | https://trialsitenews.com/ In the first edition of CATalyst, Shabnam Palesa Mohamed engages Advocate Dipali Ohja (IBA), Dr Pierre Kory (FLCCC), and Dr Tess Lawrie (EBMC) about the Indian Bar Association's decision to issue legal notice on WHO chief scientist, Dr Soumya Swaminathan. The 51 page notice, served 25th of May, cl…
…
continue reading
We sit down with Ralph Lorigo, of the Law Office of Ralph C. Lorigo to discuss NY court cases regarding Ivermectin and Covid-19. His firm have represented a number of elderly patients who have taken on their respective hospitals who refused to continue to administer doctor prescribed Ivermectin for the treatment Covid-19. This episode does not disc…
…
continue reading
Shabnam Palesa Mohamed: Activist. journalist, mediator (LLB). Founder of SAHARI and THJ CEO, discusses state of Ivermectin in South Africa. We discuss the twists and turns of the legality issues of the drug, to a campaign to bring awareness through-out the country and beyond. Petition Link: https://www.change.org/p/president-cyril-ramaphosa-south-a…
…
continue reading
We talk with Dr. Kedar about rural research initiatives and the impact Covid-19 has had in bringing advanced research to them. Dr. Kedar specializes in autoimmune diseases that effect the musculoskeletal system, such as rheumatism, arthritis, and other disorders of the joints, muscles and ligaments. Dr. Kedar's Website: https://www.ruralamericaandc…
…
continue reading
Today we’ll be touching on a tough subject, Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord. Essentially, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause permanen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sam Searcy Talks Accelerating The Clinical Trials Process With Cloud-Based Service Providers
11:52
We sit down with Sam Searcy to talk about his Company Clinistart, and innovative cloud-based service providers designed to accelerate clinical trial site activation and study start up. The goal: accelerate each step of the clinical trials process to accelerate the availability of medicines sooner for patients. You can check out Clinistart by clicki…
…
continue reading
We sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started a first-in-human clinical research study involving a new surgical technique to treat glioblastoma multiforme (GBM) - the most aggressive form of brain cancer. Dr. Boockvar was one of the neurosurgeons featured on the highly praised Ne…
…
continue reading
An interview with Dr. Gerald Maguire about the Phase 2 Speak Freely Study, which is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, exploratory study in adult subjects with childhood onset fluency disorder. Essentially a study directed at adults with stuttering. About Gerald A Maguire, MD, DFAPA Professor and Chair, Psy…
…
continue reading
We discuss "Smart" Natural Killer Cells for Cancer Treatment, Sonny Hsiao of Acepodia. A clinical trial targeting HER2-expressing solid tumors with “smart” NK cells. Sonny Hsiao is the founder and CEO of Acepodia. Founded in 2016 the company seeks to develop new therapies in immune-oncology and cell therapy medicine. Put another way Acepodia is a n…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. Ian Smith And Stuart Young Talk About Lessons From Covid-19: Strategy For Recruiting Patients
25:16
An Interview with Dr. Ian Smith, Founder, Director and Chief Medical Officer of Panthera Biopartners and CEO of Panthera Biopartners Stuart Young discussing the Lessons from Covid-19 and the differing strategies for recruiting and retaining patients in oncology and chronic diseases including CNS, Rheumatoid arthritis, Nash and cardiovascular. About…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Claudia Christian Discusses Covid-19 Impact: Challenge of Patient Recruitment in Clinical Trials
16:10
Claudia Christian of FHI Clinical discusses Covid-19 impact on Clinical Trials. The challenge of patient recruitment in Clinical Trials Claudia Christian is the Senior Vice President, Clinical Operations of FHI Clinical. FHI Clinical has, among other things provided clinical operations services for ACTT-1 trial of remdesivir for treatment of COVID-…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. Abribat talks Amolyt Pharma: Advance therapeutic peptides treat endocrine and metabolic diseases
16:17
We sit down and talk to Dr. Abribat about Amolyt Pharma, which is developing therapeutic peptides to treat rare endocrine and metabolic diseases. The company recently announced that it has dosed the first patient in a Phase 1 clinical trial evaluating its experimental therapeutic peptide, AZP-3601, for a life-altering rare disease called hypoparath…
…
continue reading
Dr. David Horn Solomon, CEO of Pharnext discusses PXT3003 which is currently focused on the treatment of Charcot Marie-Tooth (CMT) disease Type 1A. Charcot-Marie-Tooth is a degenerative nerve disease that usually appears in adolescence or early adulthood. CMT affects the Peripheral Nervous System. It is a progressive nerve disease. Nerves weaken ov…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr Lenze of Washington University St. Louis Talks Antidepressant Fluvoxamine Covid-19 Clinical Trial
17:15
Dr. Lenze discusses a clinical trial conducted by Washington University School of Medicine in St. Louis which evidences the potential that fluvoxamine, an antidepressant, may prevent COVID-19 infections from worsening. This trial is based on recent research that originates from the University of Virginia School of Medicine. Website: https://stopcov…
…
continue reading
Dr. Ragen discusses X4 Pharmaceuticals, which is currently developing therapies for rare genetic diseases that result from dysfunction of the immune system and is currently undergoing a global Phase 3 trial for WHIM Syndrome and two Phase 1b trials for Waldenstrom macroglobulinemia (WM), a type of rare lymphoma, and severe congenital neutropenia (S…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. CJ Barnum of INmune Bio | NIH Grant tests Neuroinflammation on Treatment Resistent Depression
18:04
We sit down with Dr. CJ Barnum, Director of Neuroscience at Inmune Bio, Inc. to talk about the recently announced grant from the NIH for $2.9 million to test a new hypothesis that #neuroinflammation plays a major role in treatment resistant depression (TRD). This money will support a first-of-its-kind phase 2 study that will be conducted at two sit…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hartmut Ehrlich and Philippe Pouletty discuss Abivax Clinical Programs Involving Covid-19 and more.
33:24
Hartmut Ehrlich and Philippe Pouletty discuss Abivax Pipeline of Clinical Programs involving Covid-19, Ulcerative Colitis, Crohn's Disease and more. https://www.abivax.com/pipeline/ - #COVID-19 https://www.abivax.com/pipeline/abx464-for-covid-19/ Ongoing Phase 2b/3 trial with ABX464 in Covid-19 (miR-AGE trial), the unique properties of the lead can…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study | Podcast S2 E45
30:01
Dr. Negin Hajizadeh discussing Feinstein Institutes researchers finding an effective COVID-19 ‘cytokine storm’ treatment and more. Dr. Hajizadeh is an ICU pulmonologist and was a part of Northwell Health's, NY largest health system, at the height of the surge. She has experienced and delivered care first hand. She is also a researcher with the Fein…
…
continue reading
Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC: Dr. Pierre Kory, Associate Professor of Medicine at St. Luke’s Aurora Medical Center and who TrialSite News would classify as a Pulmonologist and ICU specialist dedicated completely to the COVID-19 patient. He has been a shining light in what can be a dark and murky time in his intense commi…
…
continue reading
Dr. Richard Furie discuss his recent involvement with the Phase 3 BLISS-LN clinical trial that is setting the stage for the first ever FDA approved drug for lupus nephritis. Dr. Furie is a professor at the Feinstein Institutes for medical research, Northwell Health’s science arm of the health system. Regarded as one the senior rheumatologists in th…
…
continue reading
We sit down with Alan Cannell, who has been a collaborator with TrialSite News down in Brazil and talk about treatments for Covid-19. An engineer by training he is originally from the Isle Of Man between Scotland and Ireland and moved to Brazil IN THE 1970s and now has a family there. He has been applying his methodical engineering mindset to study…
…
continue reading
Dr. Peter McCullough sits down to talk with TrialSite News about Pathophysiologic Rationale for Early Ambulatory Treatment for COVID-19 as an Emergency Response to the Pandemic. Dr. McCullough is board certified by the American Board of Internal Medicine in internal medicine and cardiovascular disease. He has a Masters in Public Health in Epidemiol…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. Bruce Patterson Talks Monitoring of COVID-19 as it Relates to Disease Course and Therapy | Podcast S2 E40
41:00
Dr. Bruce Patterson, a decorated scientist and well-known physician as well as CEO & Co-Founder of IncellDx. Dr. Bruce Patterson talks about COVID-19 and any possible similarities between the HIV/AIDS epidemic and the SARS-COV2 virus. To learn more go here and hereDi TrialSite News
…
continue reading
Mark Erlander, Chief Executive Officer at #CardiffOncology, Inc. talks #KRAS mutations in cancer, and existing products like mCRC, mCRPc and AML, along with three clinical programs including Zytiga-Resistant Metastatic Castration Resistant Prostate cancer (mCRPC); KRAS mutated Metastatic Colorectal #Cancer (mCRC) and Relapsed/Refractory Acute Myelo…
…
continue reading
Kathryn Ardizzone of KEI discusses COVID-19 vaccine and treatment contracts obtained by KEI from the USG under the Freedom of Information Act. The government's investment in COVID-19 vaccines and treatments. The Bayh-Dole Act and its implications for COVID-19 technologies, and efforts to get around the Bayh-Dole Act by using Other Transaction Agree…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Jason Baumgartner of BEKHealth Corporation Talks About The Current State of Research Operations in a COVID World| Podcast S2 E37
26:39
Jason Baumgartner, a graduate from Duke University, both undergrad and MBA, has established a successful career in the world of clinical trials and drug development. In 2017 Jason founded BEKHealth Corporation. BEKHealth Corporation has advanced solutions working with health systems and their electronic medical records to support and facilitate cli…
…
continue reading
Today we have Dr. Hebbar from CalciMedica joining us today. Dr. Hebbar has 10+ years of clinical development and product development experience in both the pharmaceutical and diagnostics industries. Now, Privately held CalciMedica is dedicated to the discovery and development of novel small molecule drugs for the treatment of autoimmune disorders, …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Roseanne Onyia of Clinique Research Development Limited Talks with us About Clinical Research in Nigeria
13:20
Today we welcome Roseanne Onyia Founder of a Clinical Research Organization in Nigeria called Clinique Research Development Limited. TrialSite suggested in previous writings that perhaps clinical research could represent a framework to bring together healthcare assets nationwide in a way that encourages innovation helping it to potentially leapfrog…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bree Burks of Veeva Systems Discusses What Clinical Trials Will Look Like Post COVID-19 | Podcast S2 E 34
31:09
Bree Burks talks about how Clinical trials have gone through a transformation since the onset of COVID-19. Where and when possible research sponsors are moving to remote, decentralized or so-called virtual trials. She also discusses the ongoing challenges with the study start-up process and how her companies SiteVault Free eRegulatory solution for …
…
continue reading
Discussion with Dr. Jordan Dubow, about addressing the unmet need in the narcolepsy treatment landscape. Dr. Dubow has an impressive track record working in research, in the clinic, in health systems, in biotech companies, an impressive array of medical and research experience with an emphasis on neurology and vascular neurology. Check out Avadel P…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hoag Family Cancer Institute | Nascent Biotech: Clinical Trial to Fight Deadly Brain Cancer | Podcast S2 E 32
32:01
We talk with Dr. Michael Brant-Zawadzki and Dr. Burton Eisenberg Hoag is First in Nation to Test Innovative Antibody Brain Cancer Drug; clinical trial for a novel immunotherapy treatment that holds considerable promise for glioblastoma (GBM), the deadliest form of brain cancer; Hoag's research and clinical trials. To learn more https://www.hoag.org…
…
continue reading
Listen as we talk to Dr. Taglietti about SCYNEXIS and their drug Ibrexafungerp The press release below talks about their successful meeting with the NDA- https://ir.scynexis.com/press-releases/detail/216/scynexis-reports-successful-completion-of-pre-nda-meetings recently for Ibrexafungerp for the treatment of VVC, the common fungal infection affect…
…
continue reading
In this episode of TrialSite News Podcast we speak with Dr. Theresa Deisher about supercharging the body's own natural immune response; a potential solution to global pandemics, no-option cancers, and auto-immunity. AVM Biotechnology's lead product, AVM0703, is based on a repurposed active ingredient (Dexamethasone) approved and in use for over 60 …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Robert Ietswaart Discusses AI, Machine learning: A Tool to Predict Drug Side Effects | Podcast S2 E 29
33:10
We talk with Robert Ietswaart about drug side effects, known as adverse drug events and how AI machine learning can possible help predict these reactions. According to some reports adverse drug reactions are responsible for about 2 million U.S. hospitalizations per year reports the Department of Health and Human Services. To learn more or to reach …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County
32:27
Today we have the pleasure of introducing Dr. Jean-Jacques Rajter a Broward Health Medical Center physician and his wife Dr. Juliana Cepelowicz Rajter, in Florida. We covered a story about Dr. Rajter back in April, where they were “pioneering” the use of the anti-parasitic drug ivermectin on COVID-19 patients. Today, we talk to with them both about…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. Raphael Stricker Talks About PrEP, Hydroxychloroquine, and Malaria Treatments for COVID-19
15:06
In this episode we speak with Dr. Raphael Stricker about PrEP, Hydroxychloroquine, and Malaria treatments for COVID-19. Dr. Raphael Stricker also does great work with Lymes Disease. Below you will find several articles on Dr. Stricker's work and more information about him overall. Lyme Disease Lyme Disease Information USMAMED Lyme Disease Mexico Tr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. Roger Seheult of MedCram talks with us about Ivermectin, medical YouTube channels and more
20:12
In this podcast we were lucky enough to have #Dr.RogerSeheult from medcram join us here to go over a variety of topics, with a focus on #Ivermectin. Make sure yo go over and check his YouTube out as he's been following COVID-19 closely, and studies in relation to it. https://www.youtube.com/user/MEDCRAMvideos Or visit him at www.medcram.com #medcra…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
We Discuss Genomic Sequencing Efforts of Local COVID-19 Strains with Dr. Paraic Kenny of Kenny Lab
28:27
Below are the questions we asked Dr. Paraic Kenny about genomic sequencing and COVID-19 First before we get into COVID-19 Dr. Kenney could you tell us about yourself. It certainly is impressive that you have your own lab. Kenny Lab, What got you interested in health and medicine not to mention research? On to COVID-19 when did you first start think…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
A Discussion with Carlos Chaccour: Ivermectin and COVID-19, Scientific Rigor in Times of Urgency | Podcast S2 E 24
26:24
In this episode Carlos Chaccour will talk about potential Ivermectin use for COVID-19, the safety of Ivermectin, potential Ivermectin use for malaria, Ivermectin use for other communicable diseases and other potential uses of ivermectin. You can view more about Carlos Chaccour below: Carlos Chaccour -ISGlobal The Epidemiology and Economics of Coron…
…
continue reading
As director of neurology at Hudson Medical in New York Dr. Pitts heroically saved a women’s life back in April during the apex of the pandemic. Dr. Pitts connected with a mother of three and respiratory therapist who at one point was intubated for 16 days—sick with a severe to approaching critical form of COVID-19. Thankfully through Amy de Vos doc…
…
continue reading
400 million worldwide are impacted with rare diseases and approximately 30 million in America. With organizations like Global Genes we have come quite a ways to evangelize what amounts to very vulnerable groups. In this episode Christian Rubio talks about Global Genes and how they started, their goals, and what the future looks like, especially whi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Dr. Robert Jeanfreau Discusses the Impact of COVID-19 on Clinical Investigational Sites| Podcast S2 E 21
21:51
In this podcast Dr. Robert Jeanfreau talks about a range of specifics, from how he got involved in medicine and founded MedPharmics to MedPharmics collaboration with East Jefferson General Hospital to collect blood samples to support clinical trials addressing COVID-19 extreme cases. You can see more information about Dr. Jeanfreau and MedPharmics …
…
continue reading
Ed Seguine, CEO of Clinical Ink, talks about how hybrid trials, BYOD ePRO, and DDC can provide a valuable solution during a healthcare crisis like COVID-19 You can learn more about Ed Seguine and Clinical Ink below: https://www.clinicalink.com/virtual-trials/Di TrialSite News
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Irfan Khan, M.D. Talks About Virtual Healthcare in Clinical Trials and Research Post COVID-19
17:20
Irfan Khan, M.D. talks about COVID-19 and the effect it will have on clinical trials, CROs, IROs, and research. Dr. Khan goes over new capabilities that sites need to develop, be it virtual, home healthcare, or flexibility, and more, in order to stay competitive and keep high patient participation. Below is a summary of the questions he answers in …
…
continue reading
In this podcast Craig Lipset will discuss the following: Telehealth What technologies he thinks will come out on top after COVID-19 What process changes that might be organized in the future How do you think rural healthcare will change How studies will evolve post COVID-19 And so much more You can see more about Craig Lipset below: https://www.lin…
…
continue reading
Gidon Akler, MD talks about collecting samples and sequence genomes from COVID-19 patients. They hope this will help identify protective and risk bearing genetic factors, there would help in diagnostic and treatment methods. Below is a summary: The Israel Ministry of Health and the Israel Innovation Authority, along with Sourasky (Ichilov) Medical …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Rich Horgan Discusses Why he Started "Cure Rare Disease" and Their Investigation in Customized Therapies| Podcast S2 E16
44:04
Rich Horgan has quite a personal and unique story about how he started "Cure Rare Disease" you will want to give this podcast a listen. Cure Rare Disease has a focus on CRISPR gene-editing therapy, and how they can improve drug development for those with rare diseases. Listen below to hear about their goal to bring various groups together to find t…
…
continue reading
Dr. Tiwari's lab focuses on developing AI and image-analysis techniques for personalized diagnostics and therapeutic applications in Glioblastoma. In this Podcast she will discuss the implications of this work in regards to clinical trials and how it may have an impact not just as "virtual biopsies" but also for targeting radiation therapy treatmen…
…
continue reading